These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 26287973

  • 1. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.
    Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
    [Abstract] [Full Text] [Related]

  • 2. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M, Obi Y, Streja E, Rhee CM, Lau WL, Chen J, Hao C, Hamano T, Kovesdy CP, Kalantar-Zadeh K.
    Clin J Am Soc Nephrol; 2017 Jul 07; 12(7):1118-1127. PubMed ID: 28487345
    [Abstract] [Full Text] [Related]

  • 3. Mineral metabolites and CKD progression in African Americans.
    Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M.
    J Am Soc Nephrol; 2013 Jan 07; 24(1):125-35. PubMed ID: 23243213
    [Abstract] [Full Text] [Related]

  • 4. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
    Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K.
    Pediatr Nephrol; 2019 Jan 07; 34(1):107-115. PubMed ID: 30267239
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]

  • 6. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
    Pietrzyk B, Wyskida K, Ficek J, Kolonko A, Ficek R, Więcek A, Olszanecka-Glinianowicz M, Chudek J.
    Int Urol Nephrol; 2019 Mar 07; 51(3):519-526. PubMed ID: 30584645
    [Abstract] [Full Text] [Related]

  • 7. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.
    Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowsky LR, Streja E, Ricks J, Jing J, Nissenson AR, Greenland S, Norris KC.
    J Bone Miner Res; 2010 Dec 07; 25(12):2724-34. PubMed ID: 20614473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N.
    Clin Nephrol; 2020 Feb 07; 93(2):65-76. PubMed ID: 31793871
    [Abstract] [Full Text] [Related]

  • 11. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
    Block GA, Hulbert-Shearon TE, Levin NW, Port FK.
    Am J Kidney Dis; 1998 Apr 07; 31(4):607-17. PubMed ID: 9531176
    [Abstract] [Full Text] [Related]

  • 12. International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS.
    Nitta K, Bieber B, Karaboyas A, Johnson DW, Kanjanabuch T, Kim YL, Lambie M, Hartman J, Shen JI, Naljayan M, Pecoits-Filho R, Robinson BM, Pisoni RL, Perl J, Kawanishi H.
    Perit Dial Int; 2024 Jul 07; 44(4):275-286. PubMed ID: 38501163
    [Abstract] [Full Text] [Related]

  • 13. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
    Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, Goodman W, Cooper K.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):1021-30. PubMed ID: 25873267
    [Abstract] [Full Text] [Related]

  • 14. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
    Jovanovich A, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J, HOST Investigators.
    Clin J Am Soc Nephrol; 2012 Apr 05; 7(4):640-7. PubMed ID: 22383748
    [Abstract] [Full Text] [Related]

  • 15. Why Is the Association of Phosphorus and FGF23 with Mortality Stronger in African-American Hemodialysis Patients.
    Lau WL, Kalantar-Zadeh K.
    Am J Nephrol; 2015 Apr 05; 42(1):22-4. PubMed ID: 26288017
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients.
    Jia T, Qureshi AR, Brandenburg V, Ketteler M, Barany P, Heimburger O, Uhlin F, Magnusson P, Fernström A, Lindholm B, Stenvinkel P, Larsson TE.
    Am J Nephrol; 2013 Apr 05; 37(5):462-71. PubMed ID: 23635517
    [Abstract] [Full Text] [Related]

  • 18. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M.
    J Clin Endocrinol Metab; 2012 May 05; 97(5):1655-62. PubMed ID: 22362819
    [Abstract] [Full Text] [Related]

  • 19. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
    Lin CH, Chang CK, Shih CW, Li HY, Chen KY, Yang WS, Tsai KS, Wang CY, Shih SR.
    Osteoporos Int; 2019 Nov 05; 30(11):2289-2297. PubMed ID: 31384956
    [Abstract] [Full Text] [Related]

  • 20. The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals.
    Kamr AM, Dembek KA, Hildreth BE, Morresey PR, Rathgeber RA, Burns TA, Zaghawa AA, Toribio RE.
    Equine Vet J; 2018 Nov 05; 50(6):739-746. PubMed ID: 29660161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.